These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 23937438)
1. Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Nik NN; Vang R; Shih IeM; Kurman RJ Annu Rev Pathol; 2014; 9():27-45. PubMed ID: 23937438 [TBL] [Abstract][Full Text] [Related]
2. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Kurman RJ Ann Oncol; 2013 Dec; 24 Suppl 10():x16-21. PubMed ID: 24265397 [TBL] [Abstract][Full Text] [Related]
3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
4. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings. Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599 [TBL] [Abstract][Full Text] [Related]
5. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711 [TBL] [Abstract][Full Text] [Related]
6. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388 [TBL] [Abstract][Full Text] [Related]
7. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Kindelberger DW; Lee Y; Miron A; Hirsch MS; Feltmate C; Medeiros F; Callahan MJ; Garner EO; Gordon RW; Birch C; Berkowitz RS; Muto MG; Crum CP Am J Surg Pathol; 2007 Feb; 31(2):161-9. PubMed ID: 17255760 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma]. Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343 [TBL] [Abstract][Full Text] [Related]
9. Tubal origin of ovarian cancer - the double-edged sword of haemoglobin. Lin SF; Gerry E; Shih IM J Pathol; 2017 May; 242(1):3-6. PubMed ID: 28054715 [TBL] [Abstract][Full Text] [Related]
10. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Seidman JD; Zhao P; Yemelyanova A Gynecol Oncol; 2011 Mar; 120(3):470-3. PubMed ID: 21159368 [TBL] [Abstract][Full Text] [Related]
11. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
12. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Gao FF; Bhargava R; Yang H; Li Z; Zhao C Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279 [TBL] [Abstract][Full Text] [Related]
14. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum]. Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778 [TBL] [Abstract][Full Text] [Related]
15. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Roh MH; Kindelberger D; Crum CP Am J Surg Pathol; 2009 Mar; 33(3):376-83. PubMed ID: 19011565 [TBL] [Abstract][Full Text] [Related]
16. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake? Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262 [TBL] [Abstract][Full Text] [Related]
17. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma]. Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294 [No Abstract] [Full Text] [Related]
18. CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma. Kuhn E; Wang TL; Doberstein K; Bahadirli-Talbott A; Ayhan A; Sehdev AS; Drapkin R; Kurman RJ; Shih IeM Mod Pathol; 2016 Oct; 29(10):1254-61. PubMed ID: 27443516 [TBL] [Abstract][Full Text] [Related]
19. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Roh MH; Yassin Y; Miron A; Mehra KK; Mehrad M; Monte NM; Mutter GL; Nucci MR; Ning G; Mckeon FD; Hirsch MS; Wa X; Crum CP Mod Pathol; 2010 Oct; 23(10):1316-24. PubMed ID: 20562848 [TBL] [Abstract][Full Text] [Related]
20. [Fallopian tube: the dark face of pelvic carcinogenesis]. Watkin E; Devouassoux-Shisheboran M Ann Pathol; 2011 Oct; 31(5):345-52. PubMed ID: 21982240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]